ARCHIVES

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

This article is from The Cancer Letter archive.

Vol. 30 No. 40 | October 22, 2004

Download PDF Visit The Full Archive

Related Articles

NTP Board Okays Modification Of Bioassay Protocols

April 9, 1982

NCAB Okays Funding Core Grants For ICC, Hawaii, UC-San Diego

February 15, 1985

NIH Study Finds Sigmoidoscopy Reduces Colon Cancer Incidence and Mortality Rates

May 25, 2012

In Brief: ACS Board Names McGinnis Prsident; Fuller Re-Elected chairman; Lenhard Is Vice President

November 25, 1994

In Brief DCCP Directorship Draws 100 Names; Upon Agrees Centers Programs Needs More Staff

January 13, 1978

Assurances On Methods For Misconduct Reporting Required

December 1, 1989